Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

Clinical trial NCT07651319 · RECRUITING

Trial details

NCT number: NCT07651319
Sponsor: The Methodist Hospital Research Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Dementia (AD)

Start date: 2026-07-01
Primary completion: 2029-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.